Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Donor Robert Stockley is funding PhD student's COPD research Birmingham graduate Professor Robert Stockley has dedicated his life’s work to treating and researching a group of lung conditions that make it difficult to breathe, known as chronic obstructive pulmonary disease (COPD).
News Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, early stage research finds
14 January 2022 New ethnicity report highlights variation in health outcomes in rheumatology practice Dr Kanta Kumar together with rheumatology teams across the UK has played a key role in the Healthcare Quality Improvement Partnership report.
05 January 2022 Institute of Inflammation and Ageing Award Success The University of Birmingham's Institute of Inflammation and Ageing has been awarded four major grants.
21 December 2021 China-wide study will boost understanding of fatal surgical complication Older patients in hospitals across China took part in a major multi-centre open-label randomised clinical trial that showed there was no difference in post-operative delirium in older people with a hip fracture.
20 December 2021 University of Birmingham announces five new diabetes research studies The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.
20 December 2021 Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, early stage research finds A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
04 November 2021 Study exposes risks and benefits of virtual consultations with doctors So-called 'telemedicine' is less diagnostically accurate than in-person consultations and could increase health inequalities and barriers to accessing appropriate care.
03 November 2021 New drug treatment regimen shows promise for patients with lupus New drug treatment regimen, using belimumab soon after rituximab, reduced a disease-related autoantibody and severe disease flares in lupus patients.
27 October 2021 Specific cell population plays a key role in the affect arthritis has on the body and the pain patients feel, study finds Scientists at the University of Birmingham have led a study which has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the subsequent pain felt by patients.
22 October 2021 Artificial Intelligence project aims to improve standards and development of AI systems A new project has been launched in partnership with the University of Birmingham aiming to address racial and ethical health inequalities using artificial intelligence.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
03 September 2021 New study will use artificial intelligence to improve treatments for people with multiple long-term conditions The NIHR has awarded £2.5 million for research that will use artificial intelligence to produce computer programmes and tools to help doctors improve the choice of drugs in patients with multiple long-term conditions.
27 August 2021 New spinout Empower Therapeutics sets its sights on reducing pain 'chronification' The University of Birmingham, UK, and the University of Maryland, Baltimore have created a new spinout, Empower Therapeutics, to commercialise a simple, reliable (EEG)-based biomarker for pain sensitivity.